During the past decade, Universitätsklinikum Jena und Poliklinik für Urologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Jena und Poliklinik für Urologie" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Jena und Poliklinik für Urologie" are "Advanced Cancer" (1 trials), "Carcinoma, Renal Cell" (1 trials), "Clear-cell Metastatic Renal Cell Carcinoma" (1 trials), "Metastatic Cancer" (1 trials) and "Transitional Cell Carcinoma" (1 trials). Many other conditions were trialed in "Universitätsklinikum Jena und Poliklinik für Urologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Jena und Poliklinik für Urologie" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab/Ipilimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Jena und Poliklinik für Urologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Jena und Poliklinik für Urologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitätsklinikum Jena und Poliklinik für Urologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Jena und Poliklinik für Urologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".